%D8%A7%D8%B3%DB%8C%D8%AF_%D8%AF%D8%A7%D9%88%DA%A9%D8%B3%DB%8C%DA%A9%D9%88%D9%84%DB%8C%DA%A9Kyselina_deoxycholov%C3%A1Desoxychols%C3%A4ureDeoxycholic_acid%C3%81cido_desoxic%C3%B3lico%D8%A7%D8%B3%DB%8C%D8%AF_%D8%AF%D8%A7%D9%88%DA%A9%D8%B3%DB%8C%DA%A9%D9%88%D9%84%DB%8C%DA%A9Acide_d%C3%A9soxycholiqueAig%C3%A9ad_d%C3%AD-ocsacoileach%C3%81cido_desoxic%C3%B3licoAcido_desossicolico%E3%83%87%E3%82%AA%E3%82%AD%E3%82%B7%E3%82%B3%E3%83%BC%E3%83%AB%E9%85%B8%D0%94%D0%B5%D0%B7%D0%BE%D0%BA%D1%81%D0%B8%D1%85%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D1%8F_%D0%BA%D0%B8%D1%81%D0%BB%D0%BE%D1%82%D0%B0Dezoksiholna_kiselinaDezoksiholna_kiselinaQ425680%E5%8E%BB%E6%B0%A7%E8%83%86%E9%85%B8
about
P3781
Deoxycholic Acid Injection for the Treatment of Superficial LipomasEvaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in KoreaLong-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)Comparison of Voriconazole and Amphotericin B in Treating Patients With AspergillosisSubmental Study (Sequential Treatment Approach)Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental AreaOpen-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental AreaEfficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in BrazilEvaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental FatCryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back FatDeoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures StudyAmphotericin B to Treat Visceral Leishmaniasis in Brazilian ChildrenSafety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral LeishmaniasisPatient Experience Study of Deoxycholic Acid InjectionSafety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)Condition of Submental Fullness and Treatment Outcomes RegistrySafety Study of ATX-101 in Subjects With Varying Chin SizesA Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat RemovalStudy to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal CandidiasisStudy to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body FatSingle Infusion of Liposomal Amphotericin B in Indian Visceral LeishmaniasisPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatPhase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental FatPhase 2 Study for the Treatment of Superficial LipomasLiposomal Amphotericin B for the Treatment of Cryptococcal MeningitisSafety Study of ATX-101 for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of AgeCombination Therapy in Indian Visceral LeishmaniasisAmphotericin B Treatment in Visceral LeishmaniasisTo Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment EarlyAntifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic CancerKybella With TriamcinoloneSubcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental FatInfant Fecal Insult StudySafety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh FatEfficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the "Bra Strap Fat" RegionThree Induction Treatments on Cryptococcal MeningitisPhase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat (2010-12-31)
P4844
Q61921800-0E2565FF-584D-4A6A-A187-DE246DAF2ED1Q62054086-827CFB29-93C2-4D92-9334-CACB87DAE6AFQ62054811-88636DCC-6778-40F2-9527-03EBEE4BB9BCQ62110909-5948DEC7-0B2F-40A7-85B7-122B0C23A3D5Q62820814-43425A1A-8793-4986-861D-C29476CEBA91Q63318677-0B8BF246-F719-421E-931A-74ACFA2776C3Q63321144-3A0358F5-A013-40D2-AC22-B24FE4A636D2Q63339272-D063B690-0DD6-4D5D-9D38-9D780C3EF345Q63339361-78268436-3257-4462-AD9B-42F8832185B7Q63572685-60BF7B13-738C-4A0C-B623-F600FBF9DDCAQ63836461-E69C1640-2050-45FB-A191-420325895DB4Q63836786-DD25950D-3ABB-498B-9A05-7180A9E9232BQ64043600-CF80337E-679F-42DD-8077-A0BBE65A9220Q64351391-D0131C06-62DB-489E-AC0C-DFE850BF4510Q64354508-5755FBBA-3A13-4CDE-BFA0-2AED8CA85531Q64397071-92301ED4-EC81-4FC5-B5B8-EC93EF518089Q64397544-17B8D790-089B-4221-96EB-861683479867Q64680001-F7228F24-6440-434D-B23E-030F5C2E5824Q64696841-8A40FAEC-2EC4-4543-8135-3B403E1EA6ECQ64715698-E56F8FC4-ABEC-4A6B-A311-4F7738D0F1E5Q64721709-DE59E511-E59B-4372-8746-24516AA2C3A2Q64723082-29F098E0-A91D-4147-BD0D-1C654AB763B6Q64723146-6DD14CD7-2F84-4F0C-B7DB-094F1B1B5192Q64724637-B693D246-33FC-4E91-BC65-525F3695978CQ65358798-E94ABF0B-B0DF-487A-92DA-B63594599C1BQ65360484-B4ED1C58-18B5-4652-A493-7377B81DBE15Q65382120-2A278326-E8D9-46E6-86F2-DBCDC4FDA470Q65385458-4E1CA9FA-B782-4F61-B93D-62513CD6341DQ65389158-D6E55756-CBA5-43A9-81D5-55717449A56AQ66033104-EF05F44C-7B65-478F-AF0B-19BE138B09FFQ66067139-FDD2C78A-9116-4EEA-94A4-99C0BA502E28Q66068931-A6DD014B-D515-4ADD-A020-E8A53DB3F5D6Q66077736-B22B74EF-5E83-433F-AEB1-0CB51DB778E3Q67124420-8DB0C628-CACC-4E66-AD37-E90FE81982ACQ74282088-98EDAC45-E03A-4AB1-9BFD-67ACA4F1FE85Q74286567-B630E4B8-D071-4ED0-93D5-4E8B2C5E560BQ86169602-AA58EEED-7BCB-4775-98FB-E55093E234D8Q86170865-2D7796B4-925E-453C-92BB-E84B4890E545
P4844
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Aigéad dí-ocsacoileach
@ga
Deoxycholic Acid
@nl
Desoxycholsäure
@de
Dezoksiholna kiselina
@sh
Dezoksiholna kiselina
@sr
Kyselina deoxycholová
@cs
acide désoxycholique
@fr
acido desossicolico
@it
deoxycholic acid
@en
Ácido desoxicólico
@es
type
label
Aigéad dí-ocsacoileach
@ga
Deoxycholic Acid
@nl
Desoxycholsäure
@de
Dezoksiholna kiselina
@sh
Dezoksiholna kiselina
@sr
Kyselina deoxycholová
@cs
acide désoxycholique
@fr
acido desossicolico
@it
deoxycholic acid
@en
Ácido desoxicólico
@es
altLabel
(3α,5β,12α)-3,12-dihydroxycholan-24-oic acid
@en
3alpha,12alpha-Dihydroxy-5beta-cholanic acid
@en
7α-deoxycholic acid
@en
Acido Deoxicolico
@es
Acido Deoxicólico
@es
Acido desoxicolico
@es
Acido desoxicólico
@es
Aigéad dí-ocsaicoileach
@ga
Deoxycholic Acid
@en
Deoxycholic acid
@en
prefLabel
Aigéad dí-ocsacoileach
@ga
Deoxycholic Acid
@nl
Desoxycholsäure
@de
Dezoksiholna kiselina
@sh
Dezoksiholna kiselina
@sr
Kyselina deoxycholová
@cs
acide désoxycholique
@fr
acido desossicolico
@it
deoxycholic acid
@en
Ácido desoxicólico
@es